Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026
· Cape Town, South Africa
560-05-001
ISMRM Abstract
Functional Assessment of Interstitial Lung Disease Using Oxygen-enhanced Multiparametric MRI
Primary:
Body - Lung
Secondary:
Acquisition & Reconstruction
560-05-001 · Acquisition Strategies Across Organs and Field Strengths
· Wednesday, 13 May, 4:00 PM–4:55 PM · Digital Posters Row A
Keywords:T2 star mappingInterstitial lung disease3D Ultrashort Echo Time MRIOxygen-enhanced
Accepted
Wen Yang 1, Mingran Shao1, Qianqian Feng1, Yang Yang2, Zengping Lin3, Hongyan Zhu4
1Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
2Beijing United Imaging Healthcare Co., Ltd, Beijing, China
3Shanghai United Imaging Healthcare Co., Ltd, Shanghai, China
4United lmaging HealthcareGroup Co., Ltd, Shanghai201807. China, China
Presenting Author: Wen Yang
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nicholson AG, Ryerson CJ, Strek ME, Troy LK, Wijsenbeek M, Mammen MJ, Hossain T, Bissell BD, Herman DD, Hon SM, Kheir F, Khor YH, Macrea M, Antoniou KM, Bouros D, Buendia-Roldan I, Caro F, Crestani B, Ho L, Morisset J, Olson AL, Podolanczuk A, Poletti V, Selman M, Ewing T, Jones S, Knight SL, Ghazipura M, Wilson KC. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST. PMID: 35486072; PMCID: PMC9851481. [doi][pmid]
2. Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T, Nicholson AG, Knight SL, Raoof S, Richeldi L, Ryerson CJ, Ryu JH, Wells AU. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018 Feb;6(2):138-153. doi: 10.1016/S2213-2600(17)30433-2. Epub 2017 Nov 15. PMID: 29154106. [doi][pmid]
3. Walsh SLF, Devaraj A, Enghelmayer JI, Kishi K, Silva RS, Patel N, Rossman MD, Valenzuela C, Vancheri C. Role of imaging in progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018 Dec 21;27(150):180073. doi: 10.1183/16000617.0073-2018. PMID: 30578332; PMCID: PMC9488692. [doi][pmid]
4. Gai ND, Malayeri AA, Bluemke DA. Three-dimensional T1 and T2* mapping of human lung parenchyma using interleaved saturation recovery with dual echo ultrashort echo time imaging (ITSR-DUTE). J Magn Reson Imaging. 2017 Apr;45(4):1097-1104. doi: 10.1002/jmri.25487. Epub 2016 Oct 11. PMID: 27726231. [doi][pmid]
5. Liang J, Li J, Li Z, Meng T, Chen J, Ma W, Chen S, Li X, Wu Y, He N. Differentiating the lung lesions using Intravoxel incoherent motion diffusion-weighted imaging: a meta-analysis. BMC Cancer. 2020 Aug 24;20(1):799. doi: 10.1186/s12885-020-07308-z. PMID: 32831052; PMCID: PMC7446186. [doi][pmid]